Eidos Therapeutics Inc (EIDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EIDX | LEGN | XENE | ||
| Company | Eidos Therapeutics Inc | Legend Biotech Corp ADR | Xenon Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 127.57 | 25.40 | 56.65 | ||
| High | 128.49 | 25.60 | 57.51 | ||
| Low | 116.83 | 23.80 | 55.24 | ||
| Latest | 122.21 | 23.99 | 55.41 | ||
| Change | -6.23 | -1.94 | -1.24 | ||
| % Change | -4.85% | -7.48% | -2.19% | ||
| Volume | 335,500 | 2,478,100 | 613,400 | ||
| 20-Day Average Volume | 113,985 | 2,294,615 | 936,130 | ||
| Previous Close | 128.44 | 25.93 | 56.65 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 124.59 | 19.93 | 57.34 | ||
| 20-Day Raw Stochastic | 36.63% | 72.75% | 28.10% | ||
| 20-Day Relative Strength | 56.42 | 64.40 | 52.41 | ||
| Weighted Alpha | +136.62 | -26.90 | +43.00 | ||
| Today's Opinion | 88% Buy | 24% Sell | 80% Buy | ||
| Previous Opinion | 100% Buy | 8% Sell | 88% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.40% since 01/15/21 | +13.80% since 04/16/26 | -5.17% since 04/16/26 | ||
| Low | 116.83 on 01/25/21 | 20.80 on 04/17/26 | 55.24 on 04/23/26 | ||
| High | 131.08 on 01/20/21 | 26.72 on 04/20/26 | 59.87 on 04/17/26 | ||
| 1-Month | |||||
| %Chg | -4.30% since 12/24/20 | +39.23% since 03/23/26 | +1.82% since 03/23/26 | ||
| Low | 116.24 on 01/05/21 | 16.70 on 03/30/26 | 52.54 on 03/24/26 | ||
| High | 132.54 on 01/04/21 | 26.72 on 04/20/26 | 59.99 on 04/14/26 | ||
| 3-Month | |||||
| %Chg | +66.75% since 10/23/20 | +26.20% since 01/23/26 | +32.69% since 01/23/26 | ||
| Low | 69.38 on 10/30/20 | 16.24 on 02/04/26 | 40.29 on 02/05/26 | ||
| High | 132.54 on 01/04/21 | 26.72 on 04/20/26 | 63.95 on 03/10/26 | ||
| 6-Month | |||||
| %Chg | +178.07% since 07/24/20 | -24.25% since 10/23/25 | +34.49% since 10/23/25 | ||
| Low | 38.44 on 07/31/20 | 16.24 on 02/04/26 | 37.23 on 11/07/25 | ||
| High | 132.54 on 01/04/21 | 33.50 on 11/12/25 | 63.95 on 03/10/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,750,670 | 4,795,909 | 4,712,714 | ||
| Shares Outstanding, K | 38,873 | 184,956 | 83,190 | ||
| Annual Sales | 26,690,000 | 1,028,900,000 | 7,500,000 | ||
| Annual Net Income | -37,840,000 | -296,800,000 | -345,910,000 | ||
| Last Quarter Sales | 130,000 | 306,460,000 | 0 | ||
| Last Quarter Net Income | -30,180,000 | -30,810,000 | -105,260,000 | ||
| 60-Month Beta | -0.16 | 0.08 | 0.74 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.08 on 03/10/26 | -1.31 on 02/26/26 | ||
| Latest Earnings Date | 02/24/21 | 05/12/26 | 05/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||